ARTICLE | Clinical News
AB-1001: Phase I start
February 6, 2006 8:00 AM UTC
Abeille started an open-label, 3-month, 3-way crossover, U.S. Phase I trial in 12 healthy volunteers to compare 2 doses of AB-1001 patch with IV administration of the product. ...